News & Insights

Stay up to date with the latest industry news and trends.

Excess Reinsurance's AM Best Rating is A Testament to Excellence PA-2 Excellent (Performance Assessment)

XSRE Earns AM Best Rating Affirmation:

November 15, 2024
Business

Excess Reinsurance Celebrates 35th Anniversary: A Legacy of Protection

September 10, 2024
Business

Key Factors to Consider in a Stop Loss Partner

August 22, 2024
Insurance

What is Stop Loss Insurance

June 5, 2024
Insurance

What Is Self-Funding? Exploring Key Benefits and Details

April 19, 2024
Insurance
FDA Approves new Gene Therapy Drug for Sickle Cell Disease

FDA Approves New Gene Therapy Drugs for Sickle Cell Disease

December 21, 2023
Insurance
A Comprehensive MLR Rebate Guide: With Compliance Obligations, Deadlines, and Rules

MLR Rebates: A Guide for Employers

December 7, 2023
Business

9th Drug Added to Gene Therapy Protection

November 1, 2023
Insurance

Excess Reinsurance Achieves Performance Assessment Rating of PA-2 (Excellent) by AM Best

October 12, 2023
Business